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Abstract Objective: To determine if
gastric intramucosal pH (pHi)-guid- 
ed therapy reduces the number of 
complications and length of stay in 
the intensive care unit ( ICU) or the 
hospital after elective repair of in- 
frarenal abdominal aortic aneu- 
rysms. 
Design: Prospective, randomized 
study. 
Setting: Surgical intensive care unit 
(SICU) of a University Hospital. 
Patients: Fifty-five consecutive pa- 
tients randomized to group 1 (pHi- 
guided therapy) or to group 2 (con- 
trol). 
Interventions: Patients of group 1 
with a ph i  of lower than 7.32 were 
treated by means of a prospective 
protocol in order to increase their 
ph i  to 7.32 or more. 
Measurements and results: pHi was 
determined in both groups on ad- 
mission to the SICU and thereafter 
at 6-h intervals. In group 2, the 
treating physicians were bl inded for 
the pHi values. Complications, 
APACHE II scores, duration of en- 
dotracheal intubation, fluid and va- 
soactive drug treatment, reatment 
with vasoactive drugs, length of stay 
in the SICU and in the hospital and 
hospital mortality were r corded. 
There were no differences between 
groups in terms of the incidence of 
complications. We found no differ- 
ences in APACHE II scores on ad- 
mission, the duration of intubation, 
SICU or hospital stay, or hospital 
mortality. In the two groups the in- 
cidence of pHi values lower than 
7.32 on admission to the SICU was 
comparable (41% and 42 % in 
groups 1 and 2, respectively). Pa- 
tients with pHi lower than 7.32 had 
more major complications during 
SICU stay (p < 0.05), and periods 
more than 10 h of persistently low 
pHi  values (< 7.32) were associated 
with a higher incidence of S ICU 
complications (p < 0.01). 
Conclusions: Low pHi values 
(< 7.32) and their persistence are 
predictors of major complications. 
Treatment to elevate low pHi values 
does not improve postoperative 
outcome. Based on these data, we 
cannot recommend the routine use 
of gastric tonometers for pHi-guid- 
ed therapy in these patients. Further  
studies are warranted to determine 
adequate treatment of low pHi  va- 
lues that results in beneficial effects 
on the patient's postoperative 
course and outcome. 
Key words Abdominal  aortic 
aneurysma.  Postoperative 
complication - Intramucosal pH • 
Tonometer  •Gastrointestinal 
ischemia 
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Introduction 
A low gastr ic  in t ramucosa l  pH (pH i )  obta ined  at the 
end of  a ma jor  surg ica l  p rocedure  [1-3] or  on admiss ion  
to a surgical  in tens ive  care  unit  (S ICU)  [4-6] has been 
demonst ra ted  to pred ic t  postoperat ive  compl icat ions  
such as sepsis,  mu l t ip le  o rgan  dys funct ion  syndrome 
(MODS)  and card iac  fa i lure.  Moreover ,  pH i -gu ided  
therapy  has been repor ted  to improve  pat ients '  out-  
comes  in a genera l  in tens ive  care  unit  ( ICU)  popu la t ion  
[7] and in t rauma pat ients  [8, 9]. 
Repa i r  of  in f ra rena l  abdomina l  aort ic  aneurysm 
(AAA)  is a procedure  that  can cause major  postopera -  
t ive compl icat ions  and  even  death.  The  repor ted  in-hos-  
p i ta l  mor ta l i ty  for e lect ive  AAA repa i r  ranges f rom 5 % 
[10, 11] to 12 % [12], whereas  the inc idence  of  ma jor  com-  
p l icat ions  uch as acute  rena l  fa i lure,  b leed ing ,  i leus, car- 
d iac fa i lure,  in fect ion  and  myocard ia l  in farct ion  is re- 
por ted  to be  4 -9  % [12]. Ma jor  postoperat ive  intest ina l  
i schemia  has been d iagnosed  in i % of  pat ients  af ter  elec- 
t ive AAA repa i r  wi th  a mor ta l i ty  rate  of  50 % [13]. In ad- 
di t ion,  there  is a 15 % inc idence  of  adverse  card iac  events  
in these pat ients  dur ing  the  postoperat ive  per iod  [14]. 
The  a im of  this p rospect ive  study, there fore ,  was to 
test  whether  pH i -gu ided  t reatment  in the S ICU is bene-  
f icial for  the  postoperat ive  course  of  pat ients  schedu led  
for  e lect ive AAA repa i r  by  reduc ing  the number  of  pa-  
t ients with postoperat ive  compl icat ions .  
Materials and methods 
After institutional pproval and written informed consent, 55 con- 
secutive patients were prospectively studied. All patients were 
scheduled for elective repair of an infrarenal AAA. 
Patient groups 
Before surgery, patients were randomized into one of two groups. 
In group 1 (treatment group) the pHi was determined atregular in- 
tervals and pHi-values lower than 7.32 were treated by the attend- 
ing physician according to a predeflned treatment flow chart 
(Fig. 1). The gastric mucosal carbon dioxide tension was measured 
(ABL 620, Radiometer, Copenhagen, Danemark) and pHi calcu- 
lated [15]. In cases with a pHi of below 7.32 the physicians in 
charge treated the patient o restore this to above 7.32. In group 2 
(control group) the pHi values were obtained as in group 1, how- 
ever, the attending physicians were blinded for pHi values and 
treatment was performed according to the usual clinical guidelines: 
hemodynamics were stabilized primarily by means of intravenous 
fluids (Hetastarch, Ringer's lactate). As soon as possible, ventila- 
tion was changed from continuous mandatory ventilation with var- 
ious levels of positive nd-expiratory pressure to pressure support 
ventilation. The criteria for extubation were: when the body tem- 
perature xceeded 36°C, the patient was awake and responsive 
with a mean arterial pressure above 70 mm Hg, urine output above 
0.5 ml/kg per hour, arterial pH more than 7.35 and arterial pCO2 
below 7.0 kPa, and there were no signs of other potential complica- 
tions such as myocardial ischemia. 
Study protocol 
Starting on the day of surgery, each patient was given 40 mg ome- 
prazole intravenously at24-h intervals to reduce proton production 
in the stomach, which might potentially interfere with pHi mea- 
surements [16]. After the induction ofgeneral anesthesia, the naso- 
gastric tonometer (TRIP TGS catheter, Tonometrics, Bethesda, 
Md, USA) was inserted. Correct placement of the tonometer was 
confirmed by auscultation over the stomach as air was injected 
through the tonometer or aspiration of typical gastric ontent. Gen- 
eral anesthesia was induced with 5 mg/kg thiopentone and 2 pg/kg 
fentanyl. After muscle relaxation, the patient's trachea was intu- 
bated. Anesthesia was maintained with isoflurane and fentanyl up 
to 15 ~tg/kg. No combination of general and regional anesthesia 
was used. Carbon dioxide tension of the gastric mucosa was mea- 
sured after admittance to the SICU and thereafter at 6-h intervals. 
The tonometer was removed after the patient had been extubated. 
Measurement of pHi was performed according to the guidlines 
provided by the manufacturer of the tonometer. The tonometer's 
silicone balloon was filled with 2.5 ml 0.9 % sodium chloride solu- 
tion. After equilibration for 60 rain, the solution was aspirated 
from the balloon; the first milliliter was discarded and blood gas 
analysis was immediately performed on the remaining 1.5 ml and 
an arterial blood sample, pHi was calculated based on the Hender- 
son Hasselbalch equation: 
pHi = 6.1 + log ([arterial bicarbonate]/[time corrected tono- 
metric carbon dioxide × 0.03]) 
A pHi value above 7.34 was considered to be normal [2, 17]. In 
group 1, pHi values below 7.32 were treated by the attending phy- 
sicians. The pHi values, exact treatment and the physician's hy- 
pothesis for the low pHi were recorded. Treatment included intra- 
venous fluid bolus (Ringer's lactate, colloids, packed red cells) 
and initiation or extension of pharmacologic therapy according to 
a predefined treatment flow chart (Fig. 1) based on a pathophysi- 
ologic concept [18]. It was also at he discretion of the treating phy- 
sician to order additional diagnostic measures such as transesopha- 
geal echocardiography, pulmonary artery catheters, abdominal ul- 
trasound or additional pHi measurements. In group 2, treatment 
consisted of standard procedures guided by conventional diagnos- 
tic measures, as is common practice in our institution. 
In addition to pHi values, the following data were prospectively 
collected: duration of the surgical procedure, APACHE II score 
[19] on admission to the SICU and on day 3 of SICU treatment, 
duration of intubation, daily fluid requirement in milliliters, days 
of treatment with vasoactive drugs (patients with two vasoactive 
drugs were counted twice) and postoperative complications. After 
a patient's discharge to the ward, complications on the ward, total 
length of hospital stay or death were recorded retrospectively. 
Complications were defined as a condition that required new 
therapeutic nterventions or diagnostic procedures. The complica- 
tions were divided into a major and a minor category. Major com- 
plications were defined as myocardial infarction, sustained myo- 
cardial ischemia (> 4 h), nosocomial infection according to the 
Center for Disease Control criteria [20], organ insufficiency ac- 
cording to Knaus [21] and surgical complications requiring a sec- 
ond laparotomy. In addition, we prospectively grouped patients 
based on pHi values on admission to the SICU to compare the inci- 
dence of complications in patients with normal (pHi > 7.32), to 
those having low (pHi < 7.32), values. 
Statistics 
The data are presented as means and standard eviations (SD) or 
ranges. Continuous variables were compared between groups 
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Flow chart for correction of low pH, values 
pH, > 7 .34  
pH~ 7.32 - 7.34 
pH, < 7.32 
normal 
borderline; 
repeat measurement soon 
ischemia of the stomach mucosa; 
t reatment repeat measurement soon. 
pH= < 7 .32  
J 
CVP 4, 
Oliguria 
(PCWP 4, ) 
(SVR I' ) 
hypovolemia? 
• fluidl replaceien~F--~ 
pH, '1" pH, 4 ,~ 
consider SG-catheter - -  
consider TEE 
hypovolemia? 
• more fluid 
,L l 
pH, t pH, 4, - -  
CVP t 
OliQuda 
(I~-~WP t) 
(SVR 1' ) 
myocardial decompensation? 
myocardial ischemia? 
• 12-lead ECG; enzymes? 
• 1. dopamine 4-8 p.g/min 
• 2. epinephrine 1-10 pg/min 
pH, t pH, 4 , -  
Fig. 1 The patients in group 1 were assigned to one of three groups 
depending on their pHi value: 1) pHi > 7.34, no intervention neces- 
sary. Check pHi after 6 h. 2) pHi between 7.32 and 7.34, borderline, 
intervention ot yet necessary. Check ph i  after 0-2 h. 3)pHi  
< 7.32, pathologic value, intervention ecessary. The attending 
physician had to treat the patient according to the flow chart. Pri- 
marily, the volume statuses of the patients were adjusted. The cen- 
tral venous pressures and urine outputs erved as individual guide- 
lines, however no absolute target values had to be reached. Addi- 
tional volume was given in the form of packed red cells, if the he- 
CVP 4, Hb < 9.0 g/I 
OILquria (PCWP 4,) oxygen transport capacity? 
(SVR 4,) • transfuse 
sepsis?, endotoxemia? 
hypovolemia? 
~ fluid replacement 
norepinephrine 1-10 p.g/min 
pH, t pH, 4, 
consider SG-catheter 
consider TEE 
myocardial decompensation 
g 
.epinepnrine 1-10 pglmin 
pH, t pH, 4, - -  
moglobin concentration decreased below 9.0 g/l. The physicians 
were free to request more invasive diagnostic measures, such as 
pulmonary artery catheters or t ansesophageal echocardiography. 
The ph i  value had to be checked immediately after the interven- 
tion and, if it had not yet increased, further diagnostic and/or ther- 
apeutic measures had to follow according to the flow chart until 
the ph i  value was 7.32 or higher. 
(CVP central venous pressure, PCWP pulmonary capillary 
wedged pressure, SVR systemic vascular resistance, SG Swan- 
Ganz, TEE transesophageal echocardiography) 
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Table 1 Preoperative patient data (ASA class American Society of 
Anesthesiologists physical status class [39], POVD peripheral oc- 
clusive vascular disease). No difference between groups i and 2 (un- 
paired Student's t-test, Mann-Whitney U test, Fisher's exact ext) 
Groupl (n=29) Group2 (n=26) 
Age (years) 64 _+ 10 67 _+ 9 
ASA class 3 a _+ 0.5 3 a + 0.6 
Coronary heart disease 13 (45%)  13 (50%) 
Previous myocardial 
infarction 9 (31% ) 11 (42 %) 
Arterial hypertension 18 (62 % ) 16 (62 % ) 
Diabetes mellitus 1 (3 % ) 2 (8 %) 
POVD 17 (59%) 13 (50%) 
a median 3(range 2-4) 
using the two-sided unpaired Student's t-test, while comparison of
scores was performed using the Mann-Whitney U test. Contingen- 
cy tables were tested using Fisher's exact est. A p value less than 
0.05 was considered significant. 
Results 
There were no differences between groups with respect 
to age or previous medical conditions (Table 1) or dura- 
tions of the operative procedures and APACHE II 
scores on admission to the SICU (Table 2). There were 
also no differences between groups in terms of duration 
of intubation, perioperative fluid requirement,  dura- 
tions of the SICU and hospital stays. Patients in group 1 
received more vasoactive drugs on postoperat ive day 1 
compared to group 2 (p < 0.05). APACHE II scores on 
postoperative day 3 were higher (p < 0.05) in group 2 
patients (Table 2). 
The incidence and severity of complications for the 
two groups are shown in Table 3. There were no statisti- 
cally significant differences. However, there were more 
major complications in patients with pHi values below 
7.32 on admission to the SICU (p < 0.05), while this dif- 
ference did not reach statistical significance within 
treatment groups (Table 4). There was a high incidence 
of pHi values lower than 7.32 in both groups (41% and 
42 % in groups 1 and 2, respectively). This incidence in- 
creased within 48h  to 55% (group l)  and 65% 
(group 2) (not significant). 
In group 1, pHi  remained normal (_> 7.35) in 13 pa- 
tients during the measuring period. A total of 22 epi- 
sodes of pHi values below 7.32 were observed in 
16 patients (55 %). Nineteen of these episodes (86 %) 
were treated with additional intravenous fluids while 
in eight episodes (36 %),  in addition to fluids, a new 
vasoactive drug was started or the dosage of the va- 
soactive drugs had to be increased, and in one episode 
the use of an antiarrhythmic drug was chosen. During 
three episodes of low pHi  values (< 7.32), the attend- 
ing physician requested an additional diagnostic mea- 
sure: one transesophageal echocardiography, one ab- 
dominal ultrasound and one 12-lead electrocardio- 
gram. In three episodes (14%),  the physicians ques- 
tioned the validity of the low pHi values because of 
the good clinical recovery and the normal values of 
all other monitor ing parameters of the patient. In 
each of these cases the ph i  measurement was repe- 
ated immediately and revealed normal values in all in- 
stances. 
To determine whether the treatment regime was fol- 
lowed adequately in group 1 patients, we compared the 
difference of the total amount of intravenous fluids gi- 
ven during the first S ICU day between patients with 
pHi below 7.32 and patients with pHi of 7.32 or higher. 
There was a significant difference in the total amount 
Table 2 Intraoperative and postoperative data 
Group 1 (n = 29) 
mean 
Group 2 (n = 26) 
SD mean SD 
Duration of operation 
APACHE II (admission) 
APACHE II (SICU day 3) 
Days on SICU 
Days intubated 
Total days in hospital 
Total intraoperative fluids (ml) 
Total fluids (ml; SICU day 1) 
Total fluids (ml; SICU day 3) 
Vasoactive drugs (SICU day 1) 
Hospital mortality 
189 77 193 73 
11 a 4 13 b 5 
11 c 7 19 d'e 4 
3 g 9 4 k 7 
3 h 9 31 6 
18 i 10 18 m 10 
8824 4048 9404 4812 
4862 2131 4812 4399 
3669 1822 3462 1560 
20 (69%) f 10 (38%) 
1 (3%) 2 (8%) 
a, 9 (4--24) [median (range)]; b, 12 (5-24) [median (range)]; c, 10 
(3-21) [median (range)]; a, p < 0.05 (group 1: n = 6; group 2: n = 5; 
Student's t-test); e, 18 (15-25) [median (range)]; f,p < 0.05 (Fish- 
er's exact est; patients receiving two vasoactive drugs were coun- 
ted 
twice); g, 1 (1-48) [median (range)]; h, 1 (0--48) [median (range)], 
i 14 (10-54) [median (range)]; k, 2 (1--33) [median (range)]; 
i 1 (0-33) [median (range)]; m, 14 (9-49) [median (range)] 
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Table 3 Number of patients with postoperative complications and There were no differences in the number of patients with compli- 
their nature. For every location (SICU or ward) the patients were cations between groups 1 and 2 (Fisher's exact test) 
assigned either to the group with major or minor complications. 
Complications Group I (n = 29) Group 2 (n = 26) 
SICU Major 3 10 % Myocardial infarction 4 15 % Sepsis, hemorrhagic colitis 
Intraabdominal arterial bleeding Intraabdominal arterial bleeding 
Multiple organ dysfunction Cardiac failure, sepsis 
syndrome Cardiac and pulmonary failure 
Minor 6 21% Allergic reaction 3 12 % Peripheral neurologic deficiency 
2 arrhythmias Bronchitis 
2 femoral artery occlusions Arrhythmia 
Atelectasis 
Ward Major 4 14 % Insufficiency of aortic anastomosis 4 15 % 
Pneumonia 
Sepsis 
mechanical ileus 
Minor 6 21% 2 arrhythmias 7 27 % 
Bronchitis 
Arterial microemboli 
Local soft tissue infection 
Atelectasis 
Total Major 7 24 % 8 31% 
Minor 12 41% 10 38 % 
Sepsis, hemorrhagic colitis 
Massive pulmonary embolism 
2 cardiac failures 
sinusitis 
Femoral artery occlusion 
Arterial microemboli 
2 urinary tract infections 
Subileus, arrhythmia 
Paralytic ileus 
Table 4 Subgroups defined by pHi on admission to the SICU 
Complications Group 1 (n = 29) Group 2 (n = 26) Total (n = 55) 
pHi _> 7.32 pHi < 7.32 pHi ~> 7.32 pHi < 7.32 pHi _> 7.32 pHi < 7.32 
(n = 17) (n = 12) (n = 15) (n = 11) (n = 32) (n = 23) 
SICU Major 0 3 a 1 3 1 6 b 
Minor 5 1 3 0 8 1 
Ward Major 3 1 3 1 6 2 
Minor 4 2 5 2 9 4 
a p = 0.06 compared with pHi ~> 7.32; b p < 0.05 compared with pHi _> 7.32 (Fisher's exact test) 
of fluids (pHi < 7.32:5833 ml + 2340 ml; pHi ~> 7.32: 
4176 + 1725; p < 0.05). 
In group 1, 10 episodes (45 %) of pHi values lower 
than 7.32 had a duration of less than 5 h, seven episodes 
(32%) lasted between 5 and 10h and five episodes 
(23 %) persisted over 10 h. All three patients in group 1 
who had major complications during their S ICU stay 
also had prolonged periods (i. e., > 10 h) of gastrointes- 
tinal mucosal ischemia. None of the individuals with 
short episodes (n -- 17) of pHi values below 7.32 sus- 
tained major complications in the SICU (p < 0.01 pro- 
longed versus short episodes of low pHi). 
Discussion 
Postoperative complications after AAA repair often oc- 
cur and are undesired because they can lead to MODS. 
In spite of a variety of treatment regimens, the outcome 
of patients with MODS has not improved, and this syn- 
drome is the leading cause of S ICU deaths [22]. Gastro- 
intestinal mucosal ischemia is considered to be one of 
the triggering events for the development of MODS.  
Early treatment of gastrointestinal mucosal ischemia is 
of crucial importance because the risk of serious compli- 
cations increases with t e duration of ischemia [4]. For 
these reasons, monitor ing and correction of pHi  may 
be a rational approach to treat gastrointestinal ischemia 
and, thus, to prevent MODS [17]. 
The main findings of this study were: 1 )The  inci- 
dence of postoperative gastrointestinal mucosal ische- 
mia is high, 2 ) low pHi values on admission to the 
S ICU and prolonged periods of pHi below 7.32 are asso- 
ciated with more major complications, 3) the use of pHi  
as a guide for postoperative S ICU therapy after resec- 
tion of AAA is not superior to routine treatment. 
We found an incidence of about 40 % of patients with 
pHi values below 7.32 on admission to the SICU. The 
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reported incidences of gastrointestinal mucosal is- 
chemic episodes (as indicated by low phi  values ob- 
tained from gastric or sigmoid tonometers) after AAA 
repair range from 10 to 100 %; however, the data are dif- 
ficult to compare because of differences in definitions of 
pathologic pHi values and measuring sites: either in the 
stomach or in the large bowel [3, 23-25]. 
The results of the present study corroborate previous 
findings that demonstrate low pHi values on admission 
to the SICU are associated with an increased incidence 
of postoperative complications [1-6]. Our data are also 
in line with results uggesting that prolonged periods of 
low pHi values are associated with an increased risk for 
an adverse SICU outcome [4]. However, in contrast to 
previous tudies [7-9], we were unable to demonstrate a 
beneficial effect of pHi-guided therapy on mortality and 
the incidence of complications. One explanation for the 
discrepancy may be the differences in mortality rates in 
controls. Gutierrez et al. [7] reported an excessively high 
in-hospital mortality of 58 % in controls with a pHi of 
7.35 or higher at the time of admission to the ICU. An al- 
ternative explanation may be the differences inthe study 
populations: Gutierrez et al. investigated a heterogenous 
ICU population with a high incidence of organ failures on 
admission and, consequently, higher APACHE II scores, 
while Ivatury et al. studied trauma victims with hospital 
mortalities between 30 % and 50 % [8, 9]. 
Another explanation for our failure to demonstrate 
beneficial effects of pHi-guided therapy may be that 
the therapeutic steps used to correct low pHi values 
were inadequate or were not accurately performed. 
Our flow chart is consistent with recent work demon- 
strating that certain therapies, mainly the infusion of 
various vasoactive drugs, are able to change pHi 
[26-33]. However, these studies were performed in sep- 
tic patients, and the end points for treatment were im- 
provement of splanchnic blood flow and oxygen trans- 
port variables. For example, infusion of dopexamine 
has been demonstrated to increase pHi in septic patients 
[27] whereas epinephrine causes a decrease of pHi in si- 
milar patients [33]. None of these studies provided in- 
formation as to whether an increase in pHi had any ben- 
eficial effect on patient outcome. The patients in 
group 1 with a pHi below 7.32 during the first SICU 
day received more fluids than patients with a pHi of 
7.32 or above, demonstrating, in part, that our treatment 
regimen was followed adequately. Why the total amount 
of fluids administered to group 1 and 2 patients was not 
statistically different remains unclear. We hypothesize 
that the conventional, indirect signs of hypovolemia, 
such as decrease of urine output, in our group 2 patients 
were sufficient to trigger adequate treatment with fluids 
and, therefore, knowledge of the pHi values was not 
mandatory for treating hypovolemia n these patients. 
In healthy volunteers, hypovolemia (25 % reduction 
of intravascular blood volume) is associated with a de- 
crease in pHi that is fully reversible after restoration of 
intravascular volume [34]. Based on these data and the 
fact that postoperative hypovolemia s common after in- 
frarenal AAA repair, we hypothesized that a decrease 
in pHi in our patients most likely reflects intravascular 
hypovolemia. We, therefore, decided to treat patients 
with low pHi values by administering additional fluid 
and/or vasoactive drugs. Using these measures, we suc- 
cessfully treated 77 % of the low pHi episodes within 
10 h. In the remaining episodes, however, failure to cor- 
rect pHi within 10 h was associated with major compli- 
cations during the SICU stay, a finding consistent with 
previously reported data [4]. For this reason we feel 
that the failure to correct ph i  in these patients reflects 
inadequacy of our treatment regimen. On the other 
hand, we are unaware of any therapeutic option in addi- 
tion to those we used that has been demonstrated ither 
to increase low pHi values or to have a beneficial effect 
on the patient's postoperative course. In order to elimi- 
nate these uncertainties in the future, it will be neces- 
sary to investigate carefully the effects of various treat- 
ment regimes on pHi in different patient categories. 
Possibly the sample size in this study was too small to 
exclude a type-2 statistical error. The reason we used a 
small sample size is because, at the time the study was 
planned, no data were available on the potential reduc- 
tion of complications by pHi-guided therapies so a pro- 
spective determination f the sample size was not possi- 
ble. Our data showed a reduction of 5 % for group 1 
compared with group 2 in the number of patients with 
major complications (Table 3), which was statistically 
not significant. A retrospective analysis of this reduction 
revealed that  sample size of 1000-1250 patients in 
each group would have been necessary to reach statisti- 
cal significance (Power 95 %, alpha = 0.05, two-tailed). 
These numbers demonstrate hat if there is an effect of 
pHi-guided therapy on major postoperative complica- 
tions in this patient category, this effect is very small. 
Available data on complications following AAA re- 
pair are limited to retrospective analyses and do not in- 
clude the use of pHi-guided therapy modalities. Jfirvi- 
nen et al. [12] reported 30-day postoperative complica- 
tions after elective AAA surgery in 226 patients. He 
found an overall complication i cidence of 47 %, but fo- 
cused on selected complications without rating severity. 
Diehl et al. reported that in 17 % of the patients with 
AAA repair, one or more postoperative complications 
occurred with an "operative mortality" of 5.1% [10]. 
The list of complications in this study was comparable 
to our definition of "major complications" and included 
acute renal failure, pulmonary insufficiency, myocardial 
infarction, bleeding, congestive heart failure and colon 
ischemia. Unfortunately, the authors did not differenti- 
ate between complications in the SICU and on the 
ward. It is also unclear how long the patients were fol- 
lowed, and the term "operative mortality" is not clearly 
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defined. For these reasons, comparison of our data with 
those of the above-mentioned studies is difficult. 
The results of the present study raise several points. 
First, the clinical significance of low pHi values of short 
duration is still not known. Second, the pHi value at 
which treatment should be initiated needs to be estab- 
lished [3]. Third, are there any alternative treatment 
regimens for low pHi values that have a beneficial effect 
on patient outcome? Fourth, patient categories, for ex- 
ample, patients in more serious conditions, i.e. with 
APACHE II scores higher than 20, who may benefit 
from pHi-guided therapy need to be identified. Finally, 
it remains to be established whether improvements in 
gastric tonometry, such as the use of recirculating gas to- 
nometry [35-37] or different bases for calculations (to- 
nometric minus arterial CO2 tension instead of calcu- 
lated pHi value [38]) favorably affect pHi-guided thera- 
pies in critically i l patients. 
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